The Use of Cell Free Fetal DNA in the Maternal Blood in the Evaluation of Intrauterine Fetal Demise and Miscarriage

Completed

Conditions studied: Circulating Cell Free Fetal DNA, Intrauterine Fetal Demise, Miscarriage

In brief

Women presenting to Washington Hospital Center with fetal loss would be offered participation in the study. The objective is to determine if ccffDNA obtained from maternal blood is present in the setting of missed abortion or fetal demise. The investigators primary hypothesis is that cell free fetal DNA will be present in maternal blood in the presence of a failed pregnancy.

Key facts

Study ID

NCT01916928

Run by

Medstar Health Research Institute

People needed

50

Starts

2013-05-01

Expected to finish

2014-12-01

Last updated by the study team

2017-03-13

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women diagnosed with Intrauterine fetal demised or missed abortion

You may not qualify if…

• Patients diagnosed with threatened abortion with cardiac activity present
• Patients with IUFD who have delivered the fetus (the induction process may already be in process, however, the fetus and placenta must be in situ at the time of blood sampling)
• Patients with known genetic abnormalities or mental retardation as a result of chromosomal abnormalities 13, 18, 21, or sex chromosomes.
• Children under the age of 18
• Patients not fluent in or unable to consent to the study in English

Where it is running

• Medstar Washington Hospital Center — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.